(Q35592445)

9 August 2017

title

Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case (English)

1 reference

cost-effectiveness analysis

9 August 2017

main subject

1 reference

age related macular degeneration

inferred from title

1 reference

D H Smith

1

1 reference

9 August 2017

P Fenn

series ordinal

2

1 reference

9 August 2017

M Drummond

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

British Journal of Ophthalmology

9 August 2017

published in

1 reference

9 August 2017

volume

88

1 reference

9 August 2017

issue

9

1 reference

9 August 2017

page(s)

1107-1112

1 reference

Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772332

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772332

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772332

Age-related macular degeneration

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772332

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772332

Is the incidence of registrable age-related macular degeneration increasing?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772332

Visual function index (VF-14) in exudative age-related macular degeneration of long duration.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772332

Utility values and age-related macular degeneration.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772332

The psychosocial impact of macular degeneration.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772332

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15317697

12 December 2020

inferred from PubMed ID database lookup

The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15317697

12 December 2020

inferred from PubMed ID database lookup

Assessment of vision-related function in patients with age-related macular degeneration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15317697

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/BJO.2003.023986

1 reference

9 August 2017

1 reference

9 August 2017

1 reference